https://www.selleckchem.com/pr....oducts/semaxanib-su5
1%, n = 11) and low cost. Since MET is the first-line hypoglycemic agent in patients with type II diabetes, this method can preliminarily determine MET content in urine samples, giving satisfactory results.Graphitic carbon nitride (g-C3N4) has been shown as a promising visible-light photosensitizer for photodynamic therapy (PDT) application. Nevertheless, its therapeutic efficiency is limited by the low efficiency of visible-light utilization. To overcome this issue, 3-amino-1,2,4-triazole-derived graphitic carbon nitride nanos
Like
Comment
Share
